BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Pozzato G, Mazzaro C, Dal Maso L, Mauro E, Zorat F, Moratelli G, Bulian P, Serraino D, Gattei V. Hepatitis C virus and non-Hodgkin’s lymphomas: Meta-analysis of epidemiology data and therapy options. World J Hepatol 2016; 8(2): 107-116 [PMID: 26807206 DOI: 10.4254/wjh.v8.i2.107]
URL: https://www.wjgnet.com/1948-5182/full/v8/i2/107.htm
Number Citing Articles
1
María Laura Polo, Natalia Laufer. Extrahepatic manifestations of HCV: the role of direct acting antiviralsExpert Review of Anti-infective Therapy 2017; 15(8): 737 doi: 10.1080/14787210.2017.1354697
2
Gabriele Pozzato, Cesare Mazzaro, Valter Gattei. Hepatitis C Virus–Associated Non-Hodgkin LymphomasClinics in Liver Disease 2017; 21(3): 499 doi: 10.1016/j.cld.2017.03.006
3
Francesco Bertoni, Davide Rossi, Markus Raderer, Emanuele Zucca. Marginal Zone LymphomasThe Cancer Journal 2020; 26(4): 336 doi: 10.1097/PPO.0000000000000463
4
Marine Armand, Caroline Besson, Olivier Hermine, Frédéric Davi. Hepatitis C virus – Associated marginal zone lymphomaBest Practice & Research Clinical Haematology 2017; 30(1-2): 41 doi: 10.1016/j.beha.2017.02.001
5
Stanislas Pol, Anaïs Vallet-Pichard, Olivier Hermine. Extrahepatic cancers and chronic HCV infectionNature Reviews Gastroenterology & Hepatology 2018; 15(5): 283 doi: 10.1038/nrgastro.2017.172
6
Francesco Bertoni, Davide Rossi, Emanuele Zucca. Recent advances in understanding the biology of marginal zone lymphomaF1000Research 2018; 7: 406 doi: 10.12688/f1000research.13826.1
7
Laura Milazzo, Lorena van den Bogaart, Salvatore Sollima, Letizia Oreni, Alessia Lai, Valentina Morena, Cecilia Bonazzetti, Lisa Ridolfo Anna, Spinello Antinori. Impact of HCV eradication with direct-acting antiviral agents on serum gamma globulin levels in HCV and HCV/HIV coinfected patientsEuropean Journal of Internal Medicine 2020; 75: 50 doi: 10.1016/j.ejim.2020.01.006
8
Stanislas Pol, Sylvie Lagaye. The remarkable history of the hepatitis C virusGenes & Immunity 2019; 20(5): 436 doi: 10.1038/s41435-019-0066-z
9
Clémence Hollande, Lucia Parlati, Stanislas Pol. Micro‐elimination of hepatitis C virusLiver International 2020; 40(S1): 67 doi: 10.1111/liv.14363
10
Charlotte Lybeck, Daniel Bruce, Scott M. Montgomery, Soo Aleman, Ann‐Sofi Duberg. Risk of extrahepatic cancer in a nationwide cohort of hepatitis C virus infected persons treated with direct‐acting antiviralsGastroHep 2021; 3(3): 185 doi: 10.1002/ygh2.456
11
Michele Magoni, Francesco Donato, Pietro Apostoli, Giuseppe Rossi, Pietro Comba, Lucia Fazzo, Fabrizio Speziani, Lucia Leonardi, Grazia Orizio, Carmelo Scarcella, Antonella Anastasia, Alessandra Tucci. Serum levels of polychlorinated biphenyls and risk of non-Hodgkin lymphoma: A hospital-based case-control study.Chemosphere 2019; 235: 969 doi: 10.1016/j.chemosphere.2019.06.193
12
Johad Khoury, George Nassar, Rimma Kramsky, Tarek Saadi. Extrahepatic Malignancies After Treatment with Direct Antiviral Agents for Chronic HCV InfectionJournal of Gastrointestinal Cancer 2020; 51(2): 584 doi: 10.1007/s12029-019-00293-y
13
Arpan Mohanty, Sarah Salameh, Adeel A. Butt. Impact of Direct Acting Antiviral Agent Therapy upon Extrahepatic Manifestations of Hepatitis C Virus InfectionCurrent HIV/AIDS Reports 2019; 16(5): 389 doi: 10.1007/s11904-019-00466-1
14
Cesare Mazzaro, Luigino Dal Maso, Endri Mauro, Marcella Visentini, Maurizio Tonizzo, Valter Gattei, Pietro Andreone, Gabriele Pozzato. Hepatitis C virus- related cryoglobulinemic vasculitis: A review of the role of the new direct antiviral agents (DAAs) therapyAutoimmunity Reviews 2020; 19(8): 102589 doi: 10.1016/j.autrev.2020.102589
15
L. Gragnani, G. Cerretelli, S. Lorini, C. Steidl, A. Giovannelli, M. Monti, L. Petraccia, S. Sadalla, T. Urraro, P. Caini, A. Xheka, A. Simone, U. Arena, M. Matucci-Cerinic, D. Vergani, G. Laffi, A. L. Zignego. Interferon-free therapy in hepatitis C virus mixed cryoglobulinaemia: a prospective, controlled, clinical and quality of life analysisAlimentary Pharmacology & Therapeutics 2018; 48(4): 440 doi: 10.1111/apt.14845
16
Juan Pablo Alderuccio, Alexandra Stefanovic, Daniel Dammrich, Jennifer R. Chapman, Francisco Vega, Gennaro Selvaggi, Andreas Tzakis, Izidore S. Lossos. Decreased survival in hepatitis C patients with monomorphic post-transplant lymphoproliferative disorder after liver transplantation treated with frontline immunochemotherapyLeukemia & Lymphoma 2018; 59(9): 2096 doi: 10.1080/10428194.2017.1413187
17
Stanislas Pol. Virus de l’hépatite C : une élimination programmableLa Presse Médicale 2019; 48(1): 1 doi: 10.1016/j.lpm.2019.01.001
18
Daniele Borsetto, Jonathan Fussey, Luca Fabris, Luigia Bandolin, Piergiorgio Gaudioso, Veronica Phillips, Jerry Polesel, Paolo Boscolo-Rizzo. HCV infection and the risk of head and neck cancer: A meta-analysisOral Oncology 2020; 109: 104869 doi: 10.1016/j.oraloncology.2020.104869
19
L. Couronné, E. Bachy, S. Roulland, B. Nadel, F. Davi, M. Armand, D. Canioni, J.M. Michot, C. Visco, L. Arcaini, C. Besson, O. Hermine. From hepatitis C virus infection to B-cell lymphomaAnnals of Oncology 2018; 29(1): 92 doi: 10.1093/annonc/mdx635
20
Stanislas Pol, Lucia Parlati, Michel Jadoul. Hepatitis C virus and the kidneyNature Reviews Nephrology 2019; 15(2): 73 doi: 10.1038/s41581-018-0081-8
21
Pietro A. Canetta, Jordan G. Nestor. Glomerulonephritis2019; : 459 doi: 10.1007/978-3-319-49379-4_27
22
A. Schiavinato, A. Zanetto, G. Pantano, F. Tosato, M. Nabergoj, P. Fogar, E. Piva, M. Gambato, E. Franceschet, A. Floreani, F. Farinati, P. Burra, F. P. Russo, M. Plebani. Polyclonal and monoclonal B lymphocytes response in HCV-infected patients treated with direct-acting antiviral agentsJournal of Viral Hepatitis 2017; 24(12): 1168 doi: 10.1111/jvh.12746
23
Adriano Pellicelli, Valerio Giannelli, Valerio Zoli, Giovanni Regine, Andrea Cortese, Giuseppe M Ettorre, Enrico Carmenini, Valeria Pellicelli, Luigi Rigacci. Resolution of primary hepatic marginal zone lymphoma in a hepatitis C virus-infected patient treated with a direct-acting antiviralOxford Medical Case Reports 2021; 2021(5) doi: 10.1093/omcr/omab022
24
Emilio Iannitto, Catherine Thieblemont. Indolent LymphomasHematologic Malignancies 2021; : 127 doi: 10.1007/978-3-030-55989-2_9
25
Pietro A. Canetta, Jordan G. Nestor. Glomerulonephritis2017; : 1 doi: 10.1007/978-3-319-27334-1_27-1
26
D. A. Lioznov, M. S. Nozhkin, O. V. Gorchakova, T. V. Antonova. Characteristics of HCV infection in oncohematological patientsJournal Infectology 2020; 12(1): 91 doi: 10.22625/2072-6732-2020-12-1-91-95
27
Sarah Aherfi, Philippe Colson, Gilles Audoly, Claude Nappez, Luc Xerri, Audrey Valensi, Matthieu Million, Hubert Lepidi, Regis Costello, Didier Raoult. Marseillevirus in lymphoma: a giant in the lymph nodeThe Lancet Infectious Diseases 2016; 16(10): e225 doi: 10.1016/S1473-3099(16)30051-2
28
Stanislas Pol, Sylvie Lagaye. The remarkable history of the hepatitis C virusMicrobes and Infection 2019; 21(5-6): 263 doi: 10.1016/j.micinf.2019.06.008
29
Ekaterina Borisovna Rodionova. THE ROLE OF SALIVARY GLAND BIOPSY IN DIAGNOSIS OF SYSTEMIC DISEASES AND THEIR LYMPHOPROLIFERATIVE COMPLICATIONSRussian Journal of Dentistry 2017; 21(4): 218 doi: 10.18821/1728-2802-2017-21-4-218-224
30
Michele Merli, Giuseppe Carli, Luca Arcaini, Carlo Visco. Antiviral therapy of hepatitis C as curative treatment of indolent B-cell lymphomaWorld Journal of Gastroenterology 2016; 22(38): 8447-8458 doi: 10.3748/wjg.v22.i38.8447
31
Irene Defrancesco, Caterina Zerbi, Sara Rattotti, Michele Merli, Raffaele Bruno, Marco Paulli, Luca Arcaini. HCV infection and non-Hodgkin lymphomas: an evolving storyClinical and Experimental Medicine 2020; 20(3): 321 doi: 10.1007/s10238-020-00615-6
32
Katsushi Tajima, Naoto Takahashi, Kenichi Ishizawa, Kazunori Murai, Tomoaki Akagi, Hideyoshi Noji, Osamu Sasaki, Masaharu Wano, Jugoh Itoh, Yuichi Kato, Tsutomu Shichishima, Hideo Harigae, Yoji Ishida. Clinicopathological characteristics of malignant lymphoma in patients with hepatitis C virus infection in the Tohoku district in Eastern JapanLeukemia & Lymphoma 2017; 58(6): 1509 doi: 10.1080/10428194.2016.1236376
33
Guido Carloni, Daniela Fioretti, Monica Rinaldi, Antonio Ponzetto. Heterogeneity and coexistence of oncogenic mechanisms involved in HCV-associated B-cell lymphomasCritical Reviews in Oncology/Hematology 2019; 138: 156 doi: 10.1016/j.critrevonc.2019.04.005
34
C.-E. Huang, Y.-H. Yang, Y.-Y. Chen, J.-J. Chang, K.-J. Chen, C.-H. Lu, K.-D. Lee, P.-C. Chen, C.-C. Chen. The impact of hepatitis B virus infection and vaccination on the development of non-Hodgkin lymphomaJournal of Viral Hepatitis 2017; 24(10): 885 doi: 10.1111/jvh.12713
35
Tarek Saadi, Johad Khoury. Is There a Relationship Between Treatment With Direct Antiviral Agents for HCV Infection and the Development of Malignancies?Journal of Clinical Gastroenterology 2018; 52(4): 353 doi: 10.1097/MCG.0000000000000853
36
Harrys A. Torres, Terri Lynn Shigle, Nassim Hammoudi, James T. Link, Felipe Samaniego, Ahmed Kaseb, Vincent Mallet. The oncologic burden of hepatitis C virus infection: A clinical perspectiveCA: A Cancer Journal for Clinicians 2017; 67(5): 411 doi: 10.3322/caac.21403